Multiplexed reverse-transcriptase quantitative polymerase chain reaction using plasmonic nanoparticles for point-of-care COVID-19 diagnosis
Source abstract
Abstract
Quantitative polymerase chain reaction (qPCR) offers the capabilities of real-time monitoring of amplified products, fast detection, and quantitation of infectious units, but poses technical hurdles for point-of-care miniaturization compared with end-point polymerase chain reaction. Here we demonstrate plasmonic thermocycling, in which rapid heating of the solution is achieved via infrared excitation of nanoparticles, successfully performing reverse-transcriptase qPCR (RT-qPCR) in a reaction vessel containing polymerase chain reaction chemistry, fluorescent probes and plasmonic nanoparticles. The method could rapidly detect SARS-CoV-2 RNA from human saliva and nasal specimens with 100% sensitivity and 100% specificity, as well as two distinct SARS-CoV-2 variants. The use of small optical components for both thermocycling and multiplexed fluorescence monitoring renders the instrument amenable to point-of-care use. Overall, this study demonstrates that plasmonic nanoparticles with compact optics can be used to achieve real-time and multiplexed RT-qPCR on clinical specimens, towards the goal of rapid and accurate molecular clinical diagnostics in decentralized settings.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: SARS-CoV-2 detection and testing · Biosensors and Analytical Detection · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Mullis, K. et al. Cold Spring Harbor Symposia on Quantitative Biology Vol. 51, 263–273 (Cold Spring Harbor Laboratory Press, 1986).10.1101/SQB.1986.051.01.032 ↗
2. Yang, S. & Rothman, R. E. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis. 4, 337–348 (2004).10.1016/S1473-3099(04)01044-8 ↗
3. Linz, U. Thermocycler temperature variation invalidates PCR results. BioTechniques 9, 290–293 (1990). 286, 288.
4. Schoder, D. et al. Physical characteristics of six new thermocyclers. Clin. Chem. 49, 960–963 (2003).10.1373/49.6.960 ↗
5. Schoder, D. et al. Novel approach for assessing performance of PCR cyclers used for diagnostic testing. J. Clin. Microbiol. 43, 2724–2728 (2005).10.1128/JCM.43.6.2724-2728.2005 ↗
6. Zhu, H. et al. The vision of point-of-care PCR tests for the COVID-19 pandemic and beyond. Trends Anal. Chem. 130, 115984 (2020).10.1016/j.trac.2020.115984 ↗
7. Lagally, E. T., Simpson, P. C. & Mathies, R. A. Monolithic integrated microfluidic DNA amplification and capillary electrophoresis analysis system. Sens. Actuators B 63, 138–146 (2000).10.1016/S0925-4005(00)00350-6 ↗
8. Hoehl, S. et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med. 382, 1278–1280 (2020).10.1056/NEJMc2001899 ↗
9. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl. J. Med. (2020).10.1056/NEJMoa2001017 ↗
10. Budd, J. et al. Digital technologies in the public-health response to COVID-19. Nat. Med. 26, 1183–1192 (2020).10.1038/s41591-020-1011-4 ↗
11. Harpaldas, H. et al. Point-of-care diagnostics: recent developments in a pandemic age. Lab Chip 21, 4517–4548 (2021).10.1039/D1LC00627D ↗
12. Espy, M. et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19, 165–256 (2006).10.1128/CMR.19.1.165-256.2006 ↗
13. Richardson, H. H., Carlson, M. T., Tandler, P. J., Hernandez, P. & Govorov, A. O. Experimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutions. Nano Lett. 9, 1139–1146 (2009).10.1021/nl8036905 ↗
14. Huang, X. & El-Sayed, M. A. Gold nanoparticles: optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res. 1, 13–28 (2010).10.1016/j.jare.2010.02.002 ↗
15. Rastinehad, A. R. et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc. Natl Acad. Sci. USA 116, 18590–18596 (2019).10.1073/pnas.1906929116 ↗
16. Lee, J.-H. et al. Plasmonic photothermal gold bipyramid nanoreactors for ultrafast real-time bioassays. J. Am. Chem. Soc. 139, 8054–8057 (2017).10.1021/jacs.7b01779 ↗
17. Roche, P. J. et al. Demonstration of a plasmonic thermocycler for the amplification of human androgen receptor DNA. Analyst 137, 4475–4481 (2012).10.1039/c2an35692a ↗
18. Son, J. H. et al. Ultrafast photonic PCR. Light Sci. Appl. 4, e280–e280 (2015).10.1038/lsa.2015.53 ↗
19. Dymond, J. Explanatory chapter: quantitative PCR. Methods Enzymol. 529, 279–289 (2013).10.1016/B978-0-12-418687-3.00023-9 ↗
20. Moses, S. et al. Endpoint PCR detection of SARS-CoV-2 RNA. Preprint at medRxiv https://doi.org/10.1101/2020.07.21.20158337 (2020)10.1101/2020.07.21.20158337 ↗
21. Silva Junior, J. V. J. et al. End-point RT-PCR: a potential alternative for diagnosing coronavirus disease 2019 (COVID-19). J. Virol. Methods 288, 114007 (2021).10.1016/j.jviromet.2020.114007 ↗
22. Cheong, J. et al. Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device. Nat. Biomed. Eng. 4, 1159–1167 (2020).10.1038/s41551-020-00654-0 ↗
23. Tan, S. H., Allicock, O., Armstrong-Hough, M. & Wyllie, A. L. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir. Med. 9, 562–564 (2021).10.1016/S2213-2600(21)00178-8 ↗
24. Uchehara, G., Kirk, A. G., Trifiro, M., Paliouras, M. & Mohammadyousef, P. Nano-, Bio-, Info-Tech Sensors and 3D Systems III Vol. 109690A, 31–44 (SPIE, 2019).
25. Srivatsan, S. et al. SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing. Clin. Chem. 68, 143–152 (2022).10.1093/clinchem/hvab132 ↗
26. Smyrlaki, I. et al. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat. Commun. 11, 4812 (2020).10.1038/s41467-020-18611-5 ↗
27. Ranoa, D. et al. Saliva-based molecular testing for SARS-CoV-2 that bypasses RNA extraction. Preprint at bioRxiv https://doi.org/10.1101/2020.06.18.159434 (2020).10.1101/2020.06.18.159434 ↗
28. Nagura-Ikeda, M. et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription–loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J. Clin. Microbiol. 58, e01438–20 (2020).10.1128/JCM.01438-20 ↗
29. Wyllie, A. L. et al. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. N. Engl. J. Med. 383, 1283–1286 (2020).10.1056/NEJMc2016359 ↗
30. Zhu, J., Guo, J., Xu, Y. & Chen, X. Viral dynamics of SARS-CoV-2 in saliva from infected patients. J. Infect. 81, e48–e50 (2020).10.1016/j.jinf.2020.06.059 ↗
31. Magleby, R. et al. Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019. Clin. Infect. Dis. 73, e4197–e4205 (2020).10.1093/cid/ciaa851 ↗
32. Westblade, L. F. et al. SARS-CoV-2 viral load predicts mortality in patients with and without cancer who are hospitalized with COVID-19. Cancer Cell 38, 661–671.e2 (2020).10.1016/j.ccell.2020.09.007 ↗
33. US Food and Drug Administration (2021). Template for Developers of Molecular Diagnostic Tests (accessed 21 April 2022); https://www.fda.gov/media/135900/download
34. Feng, W. et al. Molecular diagnosis of COVID-19: challenges and research needs. Anal. Chem. 92, 10196–10209 (2020).10.1021/acs.analchem.0c02060 ↗
35. Roche, P. J. et al. Real time plasmonic qPCR: how fast is ultra-fast? 30 cycles in 54 seconds. Analyst 142, 1746–1755 (2017).10.1039/C7AN00304H ↗
36. Ahmed, W. et al. Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater. Sci. Total Environ. 820, 153171 (2022).10.1016/j.scitotenv.2022.153171 ↗
37. Hamill, V. et al. Molecular detection of SARS-CoV-2 strains and differentiation of Delta variant strains. Transbound. Emerg. Dis. 1–11 (2021).10.1111/tbed.14443 ↗
38. Service, R. One number could help reveal how infectious a COVID-19 patient is. Should test results include it? Science https://doi.org/10.1126/science.abf0366 (2020).10.1126/science.abf0366 ↗
39. Fajnzylber, J. et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 11, 5493 (2020).10.1038/s41467-020-19057-5 ↗
40. Liu, Y. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 20, 656–657 (2020).10.1016/S1473-3099(20)30232-2 ↗
41. Chang, C.-k, Hou, M.-H., Chang, C.-F., Hsiao, C.-D. & Huang, T.-h The SARS coronavirus nucleocapsid protein–forms and functions. Antivir. Res. 103, 39–50 (2014).10.1016/j.antiviral.2013.12.009 ↗
42. Orig3n, Inc. Accelerated Emergency Use Authorization (EUA) Summary Orig3n 2019 Novel Coronavirus (COVID-19) Test (Orig3n, Inc.). Orig3n 2019 Novel Coronavirus (COVID-19) Test EUA Summary https://www.fda.gov/media/136873/download (2020).
43. US Food and Drug Administration (2022). In Vitro Diagnostics EUAs (accessed 21 April 2022); https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas
44. Huber, M. et al. High efficacy of saliva in detecting SARS-CoV-2 by RT-PCR in adults and children. Microorganisms 9, 642 (2021).10.3390/microorganisms9030642 ↗
45. Winnett, A. et al. SARS-CoV-2 viral load in saliva rises gradually and to moderate levels in some humans. Preprint at medRxiv https://doi.org/10.1101/2020.12.09.20239467 (2020).10.1101/2020.12.09.20239467 ↗
46. Luu-The, V., Paquet, N., Calvo, E. & Cumps, J. Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. BioTechniques 38, 287–293 (2005).10.2144/05382RR05 ↗